PL EN

Aktualności

GMP: ASEAN Countries publish Draft of a Guideline on Process Validation

05.09.2013
The member states of the Southeast Asian association (ASEAN) have released the draft of a process validation guideline under the management of Singapore. Members of the ASEAN countries are: ...

EMA: Draft policy 70: Publication and access to clinical-trial data

05.09.2013
There is growing demand from external stakeholders for full transparency, not only about the European Medicines Agency\'s deliberations and actions, but also about the data and results from ...

EMA: Guidance on format of the risk-management plan in the European Union – in integrated format

29.08.2013
This guidance covers the Parts and modules of the RMP which may be required for applications in the EU. ...

EMA: Guidance on triggers for inspections of bioequivalence trials

29.08.2013
This document represents a non-exhaustive overview of issues which are taken into account during the assessment phase. Identification of other triggers not mentioned in this document is possible. ...

GMP: EMA Guideline on the use of bovine serum in the manufacture of human biological medicinal products

29.08.2013
On 1 December 2013, the adopted Guideline on the use of bovine serum in the manufacture of human biological medicinal products will come into effect. It replaces the Note for Guidance on the use ...

FDA: ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers - Draft Guidance

29.08.2013
This draft guidance provides answers to questions from the public comments we received on the draft guidance for industry on ANDAs: Stability Testing of Drug Substances and Products (stability ...

FDA: Guidance for Industry - Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring

29.08.2013
At the beginning of August, the FDA released a guideline on monitoring of clinical trials. This document is the final version of a draft dated August 2011 in which a few comments have been ...

EMA: This paper highlight s issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration

22.08.2013
This paper highlights issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration. ...

GMP: Frequently asked GMP Question: How to reduce testing and comply with GMP?

22.08.2013
Testing active pharmaceutical ingredients, excipients and packaging materials is one of the main tasks of the quality control units in the pharmaceutical industry. It must be ensured that the ...

GMP: Interesting APIC/CEFIC Guideline for the Qualification of Contract Laboratories

22.08.2013
The guideline is supposed to define uniform requirements for the \"life cycle management\" of contract laboratories. In addition the APIC had already prepared a guideline for the management of ...

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny